Home › NDC Lookup › RxCUI directory › RxCUI 857166

Fosinopril sodium 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet — RxCUI 857166

RxNorm drug concept · Semantic clinical drug
RxCUI 857166 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI857166
Official nameFosinopril sodium 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asFNP Sodium 10 MG / HCTZ 12.5 MG Oral Tablet; fosinopril sodium 10 MG / HCTZ 12.5 MG Oral Tablet
FDA products mapped4
Package NDCs mapped8
Reported Medicaid activity (SDUD)11 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Hydrochlorothiazide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It's a water pill — it makes your kidneys flush out extra salt and water, which reduces the amount of fluid your body is holding. That directly lowers your blood pressure and reduc...
  • What exactly is hydrochlorothiazide supposed to do for me?
  • You can take it either way, but be consistent — take it the same way each time. Food does reduce absorption slightly, but what matters most is that you take it regularly as prescri...
  • Should I take it with food or on an empty stomach?
📖 Read our full Hydrochlorothiazide guide →

🕸️ Concept Web — How Fosinopril sodium 10 MG / hydrochlorothiazide 12... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Fosinopril sodium 10 MG / hydrochlorothiazide 12.5 MG Oral Tablet RxCUI 857166

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Fosinopril 50166
    • Hydrochlorothiazide 5487
    • Fosinopril / hydrochlorothiazide 261415
    • Fosinopril sodium 227278
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Fosinopril / hydrochlorothiazide Oral Tablet 372273
    • Fosinopril sodium / hydrochlorothiazide Oral Tablet 2649178
    • Fosinopril / hydrochlorothiazide Oral Product 1162674
    • Fosinopril / hydrochlorothiazide Pill 1162675
    • Fosinopril sodium / hydrochlorothiazide Oral Product 2661536
    • Fosinopril sodium / hydrochlorothiazide Pill 2659103
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Fosinopril sodium 10 MG 857165
    • Hydrochlorothiazide 12.5 MG 316047

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Fosinopril sodium 10 MG SCDC · 857165
  • Hydrochlorothiazide 12.5 MG SCDC · 316047
  • Fosinopril / hydrochlorothiazide Oral Tablet SCDF · 372273
  • Fosinopril sodium / hydrochlorothiazide Oral Tablet SCDFP · 2649178
  • Fosinopril / hydrochlorothiazide Oral Product SCDG · 1162674
  • Fosinopril / hydrochlorothiazide Pill SCDG · 1162675
  • Fosinopril sodium / hydrochlorothiazide Oral Product SCDGP · 2661536
  • Fosinopril sodium / hydrochlorothiazide Pill SCDGP · 2659103

📦 FDA Products & Package NDCs

4 products · 8 package NDCs
8 package NDCs map to RxCUI 857166 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
65862-0308-01 100 TABLET in 1 BOTTLE (65862-308-01) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
65862-0308-30 30 TABLET in 1 BOTTLE (65862-308-30) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
65862-0308-99 1000 TABLET in 1 BOTTLE (65862-308-99) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
65862-0309-01 100 TABLET in 1 BOTTLE (65862-309-01) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
65862-0309-30 30 TABLET in 1 BOTTLE (65862-309-30) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
65862-0309-99 1000 TABLET in 1 BOTTLE (65862-309-99) Fosinopril Sodium and Hydrochlorothiazide Aurobindo Pharma Limited 2009-07-09
69097-0972-07 100 TABLET in 1 BOTTLE (69097-972-07) Fosinopril Sodium and Hydrochlorothiazide CIPLA USA INC. 2020-07-24
69097-0973-07 100 TABLET in 1 BOTTLE (69097-973-07) Fosinopril Sodium and Hydrochlorothiazide CIPLA USA INC. 2020-07-24
Observed labelers: Aurobindo Pharma Limited (6) · CIPLA USA INC. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.